Bone Biologics Corp License Agreements
7 Contracts & Agreements
- Third Amendment to the Amended License Agreement between the Company and UCLA TDG, dated May 9, 2022 (Filed With SEC on June 9, 2022)
- First Amendment to the Amended and Restated License Agreement dated August 13, 2020 between the Company and the Regents of the University of California (Filed With SEC on October 7, 2021)
- First Amendment to the Amended and Restated License Agreement dated August 13, 2020 between the Company and the Regents of the University of California (Filed With SEC on April 15, 2021)
- Amended and Restated Exclusive License Agreement, dated as of March 21, 2019, by and between the Company and The Regents of the University of California (Filed With SEC on April 16, 2019)
- AMENDEDAND RESTATED EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 23, 2017)
- TENTHAMENDMENT TO THE LICENSE AGREEMENT UCControl Number 2006-03-0536 (Filed With SEC on June 14, 2016)
- NINTHAMENDMENT TO THE LICENSE AGREEMENT UC Control No. 2006-03-0536 (Filed With SEC on December 30, 2015)
